Tag: Hormones: Male
COVID-19 Hospitalization Risk Higher for Men With Hypogonadism
Odds of hospitalization higher for men receiving inadequate TTh versus those with normal testosterone concentration while receiving TTh
Testosterone Therapy for Hypogonadism Not Tied to Increased CV Risk
No evidence of increase seen for short- to medium-term cardiovascular risk, but data lacking regarding long-term safety
Testosterone Levels Increase for Obese Teen Males After Bariatric Surgery
Increases in total, free testosterone concentrations seen with bariatric surgery and weight loss in adolescent boys with severe obesity
Sex Hormone-Binding Globulin May Be Biomarker for CVD Risk in Men
Findings appear to be independent of total testosterone concentrations
Testosterone Therapy for Hypogonadism May Cut Risk for CV Events
Risk for myocardial infarction or stroke lower with testosterone therapy among men with hypogonadism and other cardiovascular risk factors
Erythrocytosis ID’d in 11 Percent of Trans Men Using Testosterone
Factors associated with erythrocytosis include tobacco use, long-acting undecanoate injections, age at initiation of testosterone
Testosterone Therapy Does Not Improve Vascular Function
Exercise training, but not testosterone, improves endothelium-dependent vascular function in men with low-normal testosterone
Cardiorespiratory Fitness Reduced With Prolonged ADT in Prostate Cancer
Increased cardiovascular mortality also seen with prolonged androgen deprivation therapy for prostate cancer
BMD Testing Rates Low in Men Initiating ADT for Prostate Cancer
